Exparel 266 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMED7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,510
Award facts
- Contract value 100% obligated
- $38,509.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38.5K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for EXPAREL 266 mg/20 mL vials. The delivery order, issued January 5, 2026, with an ultimate completion date of January 27, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. EXPAREL is a specialty surgical product utilized across Department of Defense healthcare facilities, and this delivery order represents one of numerous pharmaceutical supply orders DMS Pharmaceutical Group has fulfilled through the Defense Logistics Agency's Medical Supply Chain division.
This delivery order operates under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy established to support recurring pharmaceutical and medical supply needs of military healthcare facilities worldwide. The parent IDC, designated SPE2DR and valued at $500M with completion through December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, vaccines, and medical consumables. The company's established performance across diverse product categories and therapeutic areas demonstrates its capability to fulfill specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FMED7?
SPE2DR26FMED7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FMED7 worth?
The government has obligated $38,510 on SPE2DR26FMED7.
Is contract SPE2DR26FMED7 an order under another contract?
Yes. SPE2DR26FMED7 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMED7 competed?
The extent of competition for SPE2DR26FMED7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award